N/A N=10 Brief CBT Interventions Delivered by Nurse Care Managers to Improve Type 2 Diabetes Outcomes: Pilot Study
Diabetes Mellitus, Type 2
Primary: Acceptability Questionnaire. — 2.49 mean of scale items
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=1,087 A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Chronic Obstructive Pulmonary Disease (COPD)
Primary: Number of Subjects With Treatment-emergent Adverse Events (TEAE) — 430; 312 participants
Phase 4 N=340 The Efficacy of Claritin in Healthy Subjects
Healthy
Primary: Change in Wheal Reaction Area From Baseline --- 2 Hour — 27.5; 29.0; 30.97; 25.0 Percent change
N/A N=24 Dentine Tubule Occlusion Assessment in a Modified in Situ Model
Dentin Sensitivity
Primary: Change From Baseline in Mean Occlusion Scores After 8 Days Treatment Application — 4.38; 4.32; 4.36; 3.43 Score on a scale — p=0.5512
Phase 1 N=80 A Study to Assess the Bioequivalence of Dapagliflozin/Metformin XR Fixed-dose Combination Tablets in Healthy Subjects
Bioequivalence · Fixed Dose Combination Tablets · Healthy Male and Female Subjects
Primary: Area Under Plasma Concentration-time Curve [AUC] Under Fasted or Fed State — 236.3; 248.6; 251.6; 258.2 h*ng/mL
Phase 2 N=33 Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer
Head and Neck Cancer · Cancer of the Pharynx · Cancer of the Larynx
Primary: Llocoregional Recurrence — 27 Participants
N/A N=42 Uro-NIRS Clinical Study
Lower Urinary Tract Symptoms · Overactive Bladder
Primary: Number of Participants Reporting Downward/Flat/Upward Patterns as Assessed by Near Infrared Spectroscopy (NIRS) for BOO Diagnosis — 9; 4; 13; 4 participants
N/A N=28 Vascular and Lipid Effects of Omega-3 Fatty Acids in People With Moderately Elevated Triglycerides
Hypertriglyceridemia
Primary: Lipid Profile — 43.2; 42.7; 42.6; 130.3 mg/dL — p=0.002
N/A N=238 The AVB Study: Prospective Study Comparing the Ahmed Valve and the Baerveldt Implant for Treating Refractory Glaucoma
Glaucoma
Primary: Number of Participants With Surgical Failure (Composite Measure) — 63; 40 participants
Phase 4 N=157 Timing of Postpartum Depot Medroxyprogesterone Acetate Administration on Breastfeeding, Contraceptive Continuation, and Depression
Contraception · Postpartum Depression · Lactation
Primary: Duration of Breastfeeding Among Women Who Plan to Breastfeed Their Infants After Postpartum or Delayed (4-6 Weeks Postpartum) Initiation of DMPA — 71; 70; 4; 4…
Phase 1 N=55 Assess Safety & Efficacy of Selumetinib When Given in Combination With Standard First Line Treatment for Advanced Non-small Cell Lung Cancer
Locally Advanced or Metastatic NSCL Cancer Stage IIIB IV
Primary: Dose Limiting Toxicity (DLT) Events in Chemotherapy in Combination With Selumetinib — 3; 7; 4; 3 participants
Phase 2 N=50 Lenalidomide/Bortezomib/Dexamethasone for Multiple Myeloma (MM)
Multiple Myeloma
Primary: Objective Response Rate — 6; 16; 11; 10 Participants
Phase 2 N=146 A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
Neurofibromatosis Type 1
Primary: Paired Associate Learning (Cambridge Neuropsychological Test Automated Battery). — 15.8; 17.0; 10.3; 11.7 PAL Total Errors — p=0.51
N/A N=74 LFIT™ Anatomic CoCr Femoral Heads With X3® Polyethylene Insert Study
Arthroplasty, Replacement, Hip
Primary: Linear Wear Rate — 0.008 mm/year
N/A N=25 Nicotine Receptor Levels and Smoking Cessation
Smoking Cessation · Nicotine Addiction
Primary: Acetylcholinergic Nicotine Receptor Availability as Determined by 2FA -PET Brain Imaging. — 17.5; 26.8 Distribution Volume Ratio (Vt/fp) — p=0.037